Navigation Links
Dr. Taub to give Estabrook Research Lecture at Kessler Foundation on Nov. 28
Date:11/6/2012

West Orange, NJ. November 6, 2012. Kessler Foundation announces that The 2012 Estabrook Distinguished Research Lectureship will be given on November 28, 2011 at Kessler Conference Center, 1199 Pleasant Valley Way in West Orange, New Jersey, from 12 noon to 1:30 pm. Edward Taub, PhD, will lecture on "Constraint-induced (CI) Therapy: A Family of Treatments in Rehabilitation that Remodel the Brain." Dr. Taub is director of the CI Therapy Research Group and Taub Training Clinic at the University of Alabama at Birmingham and a professor in the Department of Psychology.

Registration is complimentary, but reservations are required. Light refreshments are included. Register for the Estabrook Lecture now!

Dr. Taub, a noted behavioral neuroscientist, developed constraint-Induced therapy, which has been shown to be effective in improving movement after stroke, traumatic brain injury, multiple sclerosis, and other neurological injuries. In this intervention, the unaffected limb is immobilized, encouraging use of the weakened limb. CI therapy produces an increase in grey matter tissue in motor areas in the cerebral cortex of both hemispheres a true remodeling of the brain. This occurs in older patients as well as children, indicating that the plasticity of the brain persists throughout the life span. Grey matter in the hippocampus also increases, indicating that the creation of new nerve cells may be involved in the therapeutic effects produced by CI therapy.

Dr. Taub has received numerous awards for his research, which has been called one of the ten most exciting lines of neuroscience research. Nearly 400 papers have been published on the effects of CI therapy.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Research could lead to preeclampsia prevention
2. Researchers discover immune pathway
3. Temple researchers show targeted cancer drug may stunt hearts ability to repair itself
4. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
5. Researchers discover how underground rodent wards off cancer
6. New research suggests standardized booster seat laws could save lives of children
7. Medical care presents update on pharmaceutical health services research
8. Penn Medicines Daniel J. Rader, M.D., receives AHAs Clinical Research Prize
9. 23andMe demonstrates comprehensive research capabilities at annual meeting for ASHG
10. New research on employment-based insurance sheds light on health care reform
11. Forum to bring together leading-edge ophthalmic researchers and investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... According to ... In an industry filled with chemical-laden beauty products, one company is going against the ... for you: Mad Hippie. The rising star in the green space is proud to ...
(Date:5/26/2016)... Lake MN (PRWEB) , ... May 26, 2016 , ... ... Stance Angle chair , furniture that may support women during pregnancy. Potential benefits ... legs and feet, improved rest and comfort and healthier levels of sitting and standing. ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The United ... treatment of androgenetic alopecia in both men and women. To date, the company is ... with FDA clearance for any adult who suffers with androgenetic alopecia. , “This ...
(Date:5/25/2016)... ... May 25, 2016 , ... “We ... Managing Partner at HealthScape Advisors. “Brad brings significant experience advising healthcare provider clients ... system accelerates with the implementation of MACRA, we believe that continuing to add ...
(Date:5/25/2016)... Kansas City, MO (PRWEB) , ... May 25, 2016 , ... ... professional, collegiate, and amateur athletics, The National Center for Drug Free Sport (Drug Free ... Drug Free Sport”. This conference, to be held July 12 – 13 in Kansas ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 2016 According to market research ... and Demand Forecast to 2022 - Industry Insights by ... published by P&S Market Research, the global insulin delivery ... and it is expected to grow at a CAGR ... pump segment is expected to witness the fastest growth ...
(Date:5/25/2016)... Texas , May 25, 2016 ... the issuance to it by the US Patent ... The company,s technology includes proprietary processes for electronic ... for health and wellness programs, HIPAA compliance and ... "Our technology ...
Breaking Medicine Technology: